<DOC>
	<DOCNO>NCT02056340</DOCNO>
	<brief_summary>Influenza ( 'flu ' ) common virus infect approximately 5-20 % population United States cause many 500,000 death worldwide year . Currently , treatment influenza infection none target inflammation cause virus . This study test whether anti-inflammatory effect statin , class drug often use treat high cholesterol , decrease severity illness patient infect influenza test marker inflammation blood record resolution influenza illness .</brief_summary>
	<brief_title>Statin Therapy Acute Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>( must present ) : 1 . Adult patient ( age &gt; 18 year ) 2 . Positive influenza DFA/RAT test result 3 . &lt; 12 hour positive influenza test result 1 . Prior statin medication use ( within 30 day positive influenza test result ) 2 . Comfort measure designation anticipate withdrawal lifesupport 3 . Atorvastatin specific exclusion : 1 . Documented liver cirrhosis liver dysfunction ( AST ALT great 240 ) 2 . Known allergy intolerance statins 3 . Rhabdomyolysis ( CPK elevation &gt; 6x normal ) 4 . Patients take following medication : cyclosporine , HIV protease inhibitor , hepatitis C protease inhibitor telaprevir , fibric acid derivative ( gemfibrozil ) , niacin , azole antifungal ( itraconazole , ketoconazole ) clarithromycin colchicine 4 . Patients unable take oral nasogastric medication plan oral intake part medical course ( eg . emergent surgical intervention ) 5 . Known pregnancy active breastfeeding 6 . Inability provide write informed consent reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>